| ||||||||||||||||||||||||
|
Be the First to know sign up for our TWITTER
New Warnings on Anti-depressants
|
MedWatch - The FDA Safety Information and Adverse Event Reporting Program The FDA asked manufacturers of the following antidepressant drugs to include in their labeling a Warning statement that recommends close observation of adult and pediatric patients for worsening depression or the emergence of suicidality when treated with these agents. The drugs that are the focus of this new Warning are: Zoloft (sertraline); Paxil (paroxetine); Luvox (fluvoxamine); Celexa (citalopram); Lexapro (escitalopram); Wellbutrin (bupropion); Effexor (venlafaxine); Serzone (nefazodone); and Remeron (mirtazapine). See the 2004 MedWatch safety summary, including links to the drug information page and the FDA Public Health Advisory, at: http://www.fda.gov/medwatch/SAFETY/2004/safety04.htm#antidepressants Disclaimer: The Alpha 1 Advocacy Alliance supplies the reader with the above information and does not endorse or receive any goods or services for reporting this information.
Return Home | Return to Education Resources | Return to Informational Resources Telephone: 540-948-6777 or 1-866-FOR-A1AA (1-866-367-2122) Fax # 540-948-6763 Copyright © 2009 Alpha-1 Advocacy Alliance, All Rights Reserved Home | Disclaimer | Privacy Policy | |||||||||||||||||||||||